Abstract

High gastrointestinal microbial diversity and clinical outcome in graft-versus-host disease patients

Highlights

  • The human gastrointestinal tract is colonized by approximately 100 trillion prokaryotic cells, most of them being obligate anaerobic bacteria (Fig. 1)

  • Dysbiosis often arises from iatrogenic factors such as surgery or oncology-associated treatments, and drugs, including chemotherapy and broad-spectrum antibiotics, which dramatically alter the structure of the microbial ecosystem [4]

  • We highlight the evidence that microbial diversity is the cornerstone of a good health, while a decreased diversity is often related to poor clinical outcomes, and especially in graft-versus-host disease (GvHD) patients

Read more

Summary

Barrier effect

Iatrogenic stress factors: drugs (antibiotics, chemotherapy...), surgery, radiotherapy Daily life stress factors: nutrition, birth, exposure to chemicals (xenobiotics). Dysbiosis: alteration of the host-microbe dialogue Reduced richness and diversity Loss of symbionts / proliferation of pathogens Barrier defect, uncontrolled local immune responses, systemic inflammation

Low diversity
Findings
Compliance with ethical standards

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.